Furthermore, CD177 exhibits distinct roles in influencing the clinical significance and prognostic value across multiple types of cancer.CD177 has been shown to significantly correlate with a favorable prognosis in breast cancer and gastric cancer, while exhibiting a negative correlation with prognosis in ovarian cancer (12–14). Here, CD177 is linked to ovarian carcinoma.